Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment - Top-Institutions - MDSpire

Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment

  • By

  • Jiayan Xu

  • Fei Qu

  • Xiaoyu Wang

  • Shuang Liang

  • Dongying Jiang

  • Zhenghua Wang

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Colorectal Surgery
    • Oncology
    • Cancer Biomarker Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Surgical Oncology
    • Translational Cancer Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Cancer Immunology
    • Biomarker Discovery

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Colorectal Surgery
    • Cancer Epidemiology
    • Molecular Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Surgical Oncology
    • Cancer Biomarker Research
    • Clinical Epidemiology

Original Source(s)

Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment

  • by Jiayan Xu, Fei Qu, Xiaoyu Wang, Shuang Liang, Dongying Jiang, Zhenghua Wang

  • April 29, 2026

Related Content

Potential targets for boron transport in boron neutron capture therapy

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

CD38+ NK cells: novel players in immunoregulation